Advances in COVID-19 mRNA vaccine development

Area of Science:

• Vaccinology
• Molecular Biology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, represents a significant global health crisis with millions of cases and deaths worldwide.
• Vaccination is identified as the most effective strategy for controlling epidemic spread and protecting public health.
• Messenger RNA (mRNA) vaccine technology has emerged as a key platform for rapid vaccine development.

Purpose of the Study:

• To provide a comprehensive review of COVID-19 mRNA vaccine technology.
• To summarize current knowledge on structural characteristics, antigen design, and delivery systems.
• To discuss industrialization, quality control, clinical trials, real-world data, challenges, and future directions for mRNA vaccines.

Main Methods:

• Literature review of scientific publications and clinical trial data.
• Analysis of structural and immunological aspects of mRNA vaccines.
• Evaluation of industrialization, quality control, and real-world effectiveness.

Main Results:

• COVID-19 mRNA vaccines exhibit advantages including rapid development, ease of industrialization, and the ability to elicit strong immune responses.
• The review covers diverse aspects from vaccine design to clinical application and post-market surveillance.
• mRNA technology shows potential for addressing new variants and future infectious disease threats.

Conclusions:

• COVID-19 mRNA vaccines are a vital tool in managing the pandemic, showcasing the potential of mRNA technology.
• Further research and development are crucial for optimizing mRNA vaccines for current and future infectious diseases.
• Addressing challenges in production, delivery, and long-term efficacy will enhance the impact of mRNA vaccine technology.